304 related articles for article (PubMed ID: 11920511)
1. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
Wilder RB; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Cancer; 2002 Mar; 94(5):1532-7. PubMed ID: 11920511
[TBL] [Abstract][Full Text] [Related]
2. Solitary plasmacytoma.
Dagan R; Morris CG; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2009 Dec; 32(6):612-7. PubMed ID: 19593082
[TBL] [Abstract][Full Text] [Related]
3. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1063-7. PubMed ID: 9719116
[TBL] [Abstract][Full Text] [Related]
4. Reossification and prognosis following radiotherapy with/without surgery for spinal solitary plasmacytoma of the bone: a retrospective study of 39 patients.
Ouyang H; Han S; Jiang L; Zhuang H; Yang S; Liu Y; Zhang L; Liu X; Wei F; Chen K; Zhou S; Liu Z
Spine J; 2020 Feb; 20(2):283-291. PubMed ID: 31546017
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in the treatment of solitary plasmacytoma.
Jyothirmayi R; Gangadharan VP; Nair MK; Rajan B
Br J Radiol; 1997 May; 70(833):511-6. PubMed ID: 9227234
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoma. Treatment results and conversion to myeloma.
Holland J; Trenkner DA; Wasserman TH; Fineberg B
Cancer; 1992 Mar; 69(6):1513-7. PubMed ID: 1540888
[TBL] [Abstract][Full Text] [Related]
7. Solitary plasmacytoma of bone vs. extramedullary plasmacytoma and their relationship to multiple myeloma.
Corwin J; Lindberg RD
Cancer; 1979 Mar; 43(3):1007-13. PubMed ID: 106950
[TBL] [Abstract][Full Text] [Related]
8. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Stewart AK
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):113-20. PubMed ID: 11316553
[TBL] [Abstract][Full Text] [Related]
9. Solitary plasmacytoma of bone and soft tissue.
Bolek TW; Marcus RB; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):329-33. PubMed ID: 8892456
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.
Ozsahin M; Tsang RW; Poortmans P; Belkacémi Y; Bolla M; Dinçbas FO; Landmann C; Castelain B; Buijsen J; Curschmann J; Kadish SP; Kowalczyk A; Anacak Y; Hammer J; Nguyen TD; Studer G; Cooper R; Sengöz M; Scandolaro L; Zouhair A
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):210-7. PubMed ID: 16229966
[TBL] [Abstract][Full Text] [Related]
11. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
Tsang RW; Campbell BA; Goda JS; Kelsey CR; Kirova YM; Parikh RR; Ng AK; Ricardi U; Suh CO; Mauch PM; Specht L; Yahalom J
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):794-808. PubMed ID: 29976492
[TBL] [Abstract][Full Text] [Related]
12. Solitary plasmacytoma of bone and soft tissues.
Tong D; Griffin TW; Laramore GE; Kurtz JM; Russell AH; Groudine MT; Herron T; Blasko JC; Tesh DW
Radiology; 1980 Apr; 135(1):195-8. PubMed ID: 7360960
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.
Knobel D; Zouhair A; Tsang RW; Poortmans P; Belkacémi Y; Bolla M; Oner FD; Landmann C; Castelain B; Ozsahin M;
BMC Cancer; 2006 May; 6():118. PubMed ID: 16677383
[TBL] [Abstract][Full Text] [Related]
14. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of solitary extramedullary plasmacytoma.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
[TBL] [Abstract][Full Text] [Related]
16. Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party.
Kilciksiz S; Celik OK; Pak Y; Demiral AN; Pehlivan M; Orhan O; Tokatli F; Agaoglu F; Zincircioglu B; Atasoy BM; Ozseker N; Yersal O; Niang U; Haydaroglu A;
Am J Hematol; 2008 Sep; 83(9):702-7. PubMed ID: 18543343
[TBL] [Abstract][Full Text] [Related]
17. Metachronous solitary plasmacytoma.
Khosa R; Seth S; Nangia S
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29054949
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors.
Suh YG; Suh CO; Kim JS; Kim SJ; Pyun HO; Cho J
Ann Hematol; 2012 Nov; 91(11):1785-93. PubMed ID: 22752147
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes After Definitive Radiation Therapy for Solitary Plasmacytoma.
Curry J; O'steen L; Morris CG; Kirwan JM; Mendenhall WM
Am J Clin Oncol; 2020 Oct; 43(10):709-713. PubMed ID: 32739971
[TBL] [Abstract][Full Text] [Related]
20. Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.
Fouquet G; Guidez S; Herbaux C; Van de Wyngaert Z; Bonnet S; Beauvais D; Demarquette H; Adib S; Hivert B; Wemeau M; Berthon C; Terriou L; Coiteux V; Macro M; Decaux O; Facon T; Huglo D; Leleu X
Clin Cancer Res; 2014 Jun; 20(12):3254-60. PubMed ID: 24714772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
